{"id":"W2558360748","doi":"10.1016/s0140-6736(16)32389-3","title":"Fulvestrant 500 mg versus anastrozole 1 mg for hormone receptor-positive advanced breast cancer (FALCON): an international, randomised, double-blind, phase 3 trial","year":2016,"lang":"en","type":"article","venue":"The Lancet","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":602,"is_retracted":false,"has_abstract":false,"ca_institutions":"Jewish General Hospital","funders":"AstraZeneca","keywords":"Anastrozole; Fulvestrant; Medicine; Internal medicine; Hazard ratio; Breast cancer; Oncology; Clinical endpoint; Population; Placebo; Aromatase inhibitor; Metastatic breast cancer; Cancer; Gynecology; Randomized controlled trial; Estrogen receptor; Tamoxifen; Confidence interval; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001386245,0.001966497,0.002098913,0.0004867091,0.0003923394,0.0009192229,0.0008842617,0.001800569,0.009488796],"category_scores_gemma":[0.001581619,0.000571034,0.001751074,0.0004311931,0.001167677,0.001313491,0.0004105546,0.002529773,0.001411657],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008153904,"about_ca_system_score_gemma":0.0008269287,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001441307,"about_ca_topic_score_gemma":0.002780876,"domain_scores_codex":[0.9995962,0.0002008693,0.00002101667,0.00007560277,0.00002877027,0.00007769204],"domain_scores_gemma":[0.9994598,0.0001856825,0.000114477,0.00005131968,0.0000296441,0.0001590603],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9828486,0.001521017,0.000190517,0.0004095311,0.0005102694,0.00002195094,0.00002941897,0.0002576275,0.001424323,0.0001301211,0.001029924,0.01162659],"study_design_scores_gemma":[0.9804721,0.01773164,0.0005497343,0.00002172657,0.0002285933,0.00001979485,0.00001325198,0.0001897684,0.0001363648,0.0001376232,0.000489453,0.000009890627],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9716249,0.01159408,0.001261506,0.002092879,0.001229114,0.004220559,0.002496048,0.0004127964,0.005068058],"genre_scores_gemma":[0.9764445,0.004957396,0.001854399,0.002301491,0.0005365525,0.004332665,0.001882841,0.00005420129,0.007635878],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009488796,"threshold_uncertainty_score":0.03174317,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06965433626529506,"score_gpt":0.3886010275041646,"score_spread":0.3189466912388696,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}